Aptiv PLC’s $3.1 Billion of Credit Facilities
August 21, 2024
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.1 billion of credit facilities made available to Aptiv PLC and certain of its subsidiaries. Aptiv PLC is a leading global technology and mobility architecture company primarily serving the automotive sector. The facilities consisted of a $2.5 billion bridge credit facility, used to partially finance the accelerated share repurchase of up to $3.0 billion of Aptiv PLC’s ordinary shares, and a $600 million term loan facility. The transactions closed on August 1, 2024, and August 19, 2024.
The Cravath team included partner Tatiana Lapushchik, of counsel Kimberly A. Grousset and associates Diane K. Mokoro, Nastassia Shcherbatsevich Li and Hannah Gehringer on banking matters; partners Andrew J. Pitts and C. Daniel Haaren and associates Sarah R. Brathwaite and Courtney T. Seager on capital markets matters; and associates Josh Banafsheha and Megan Samayoa on tax matters.
Related Practices & Industries
People
- Photo
-
-
J.D., 2000, Harvard Law Schoolcum laude
-
B.A., 1997, Barnard Collegesumma cum laude
- New York
Education
Admitted In
- Photo
-
-
M.B.A., 1995, Boston Universitywith High Honors
-
J.D., 1994, Boston University School of Lawsumma cum laude
-
B.A., 1988, Trinity College
- New York
Education
Admitted In
- Photo
-
-
J.D., 2012, New York University School of LawOrder of the Coif, Pomeroy Scholar, magna cum laude
-
B.A., 2009, Duke University
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
January 08, 2026
Genmab’s $3.5 Billion of Credit Facilities and Offering of $1.5 Billion Senior Secured Notes and $1 Billion Senior Unsecured Notes in Connection with its Acquisition of Merus
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.
Deals & Cases
December 24, 2025
Ameren’s $3.2 Billion of Revolving Credit Facilities
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with $3.2 billion of revolving credit facilities made available to Ameren Corporation and Union Electric Company (the “Missouri Borrowers”) and Ameren Corporation and Ameren Illinois Company (the “Illinois Borrowers”). Ameren Corporation is an American power company that engages in the rate‑regulated electric generation, transmission and distribution activities; and rate‑regulated natural gas distribution and transmission businesses. The facilities consisted of a $1.9 billion revolving credit facility (Missouri Borrowers) and $1.3 billion revolving credit facility (Illinois Borrowers). The transaction closed on December 10, 2025.
Deals & Cases
November 24, 2025
Thomson Reuters Corporation’s $2 Billion Revolving Credit Facility
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with a $2 billion revolving credit facility made available to Thomson Reuters Corporation, a leading AI and technology company empowering professionals with trusted content and workflow automation. The transaction closed on November 10, 2025.
Deals & Cases
October 30, 2025
Valero Energy Corporation’s $4 Billion Revolving Credit Facility
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with a $4 billion revolving credit facility made available to Valero Energy Corporation, a leading multinational manufacturer and marketer of petroleum‑based and low‑carbon liquid transportation fuels and petrochemical products. The transaction closed on October 16, 2025.
